Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 72 member C (FAM72C) is a cytoplasm-localized, protein-coding member of the FAM72 gene family, which comprises four human paralogs. FAM72C is primarily involved in cell cycle regulation, DNA metabolism, and cellular functions such as protein trafficking, membrane dynamics, and signaling. It has tissue-specific functions, notably in neural development. Dysregulation and/or hypomethylation of FAM72C are associated with several cancers (notably clear cell renal cell carcinoma, colorectal, lung, breast, and colon cancers) and serve as poor prognostic markers, linked to increased cell proliferation and tumor progression. Mutations in FAM72C have also been implicated in neurodegenerative and autoimmune diseases. Despite its disease associations and potential role as a prognostic biomarker, FAM72C currently has no established, direct interacting drugs or recognized therapeutic targeting modalities
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 72 member C (FAM72C).